COURSERA INC (COUR)

US22266M1045 - Common Stock

9.58  -0.03 (-0.31%)

After market: 9.58 0 (0%)

Fundamental Rating

5

Overall COUR gets a fundamental rating of 5 out of 10. We evaluated COUR against 66 industry peers in the Diversified Consumer Services industry. While COUR has a great health rating, there are worries on its profitability. COUR is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!



Quickly go to:

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
In the past year COUR had a positive cash flow from operations.
In the past 5 years COUR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of COUR (-11.50%) is worse than 65.63% of its industry peers.
With a Return On Equity value of -17.31%, COUR perfoms like the industry average, outperforming 48.44% of the companies in the same industry.
Industry RankSector Rank
ROA -11.5%
ROE -17.31%
ROIC N/A
ROA(3y)-15.44%
ROA(5y)-16.41%
ROE(3y)-21.25%
ROE(5y)-24.72%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

COUR has a Gross Margin (52.02%) which is comparable to the rest of the industry.
COUR's Gross Margin has been stable in the last couple of years.
COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.53%
GM growth 5YN/A

More info and screens

7

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COUR has been increased compared to 1 year ago.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

COUR has an Altman-Z score of 2.67. This is not the best score and indicates that COUR is in the grey zone with still only limited risk for bankruptcy at the moment.
COUR has a Altman-Z score of 2.67. This is in the better half of the industry: COUR outperforms 71.88% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.67
ROIC/WACCN/A
WACC9.13%

2.3 Liquidity

A Current Ratio of 2.75 indicates that COUR has no problem at all paying its short term obligations.
COUR's Current ratio of 2.75 is fine compared to the rest of the industry. COUR outperforms 76.56% of its industry peers.
COUR has a Quick Ratio of 2.75. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.75, COUR is doing good in the industry, outperforming 78.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75

More info and screens

7

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 143.70%, which is quite impressive.
Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 19.26% in the last year.
Measured over the past years, COUR shows a very strong growth in Revenue. The Revenue has been growing by 29.39% on average per year.
EPS 1Y (TTM)143.7%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q333.33%
Revenue 1Y (TTM)19.26%
Revenue growth 3Y29.39%
Revenue growth 5YN/A
Revenue growth Q2Q14.54%

3.2 Future

COUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 180.27% yearly.
The Revenue is expected to grow by 15.94% on average over the next years. This is quite good.
EPS Next Y840.67%
EPS Next 2Y305.61%
EPS Next 3Y180.27%
EPS Next 5YN/A
Revenue Next Year16.71%
Revenue Next 2Y15.96%
Revenue Next 3Y15.94%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 79.83, the valuation of COUR can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of COUR is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 28.02, COUR is valued quite expensively.
With a Price/Forward Earnings ratio of 32.35, COUR can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as COUR.
COUR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.58.
Industry RankSector Rank
PE 79.83
Fwd PE 32.35

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 60.94% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 60.1
EV/EBITDA N/A

4.3 Compensation for Growth

COUR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
COUR's earnings are expected to grow with 180.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y305.61%
EPS Next 3Y180.27%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (5/6/2024, 7:04:00 PM)

After market: 9.58 0 (0%)

9.58

-0.03 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.51B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 79.83
Fwd PE 32.35
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.5%
ROE -17.31%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 52.02%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)143.7%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y840.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.26%
Revenue growth 3Y29.39%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y